SCHEMBL7676360

SCHEMBL7676360

COCCC1=NN=C(c2cccnc2)[N]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.40
CYP3A4 P08684 4/20 0.40
ALDH1A1 P00352 4/20 0.40
CYP1A2 P05177 2/20 0.40
CYP19A1 P11511 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
HSD17B10 Q99714 3/20 0.37
LMNA P02545 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HIF1A Q16665 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
MAPT P10636 2/20 0.37
TP53 P04637 2/20 0.37
CYP2A13 Q16696 1/20 0.36
CYP11B1 P15538 3/20 0.36
CYP11B2 P19099 3/20 0.36
MKNK1 Q9BUB5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7673942 0.86 CYP2A6 (0.44) CYP2A6CYP3A4ALDH1A1CYP1A2CYP19A1
SCHEMBL7682696 0.86 CYP3A4 (0.40) CYP2A6CYP3A4ALDH1A1CYP1A2CYP19A1
SCHEMBL7676187 0.80 CYP2A6 (0.47) CYP2A6CYP3A4ALDH1A1CYP1A2CYP19A1
SCHEMBL7679937 0.78 NPC1 (0.48) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2D6
SCHEMBL7678740 0.77 CYP2A6 (0.40) CYP2A6CYP3A4ALDH1A1CYP1A2CYP19A1
SCHEMBL7674967 0.76 MKNK1 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2D6
SCHEMBL7674216 0.76 CYP2A6 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2D6
SCHEMBL7680165 0.74 TBXAS1 (0.51)
SCHEMBL7683441 0.73 CYP11B1 (0.49) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2D6
SCHEMBL7680376 0.72 KDM4E (0.47) CYP2A6CYP3A4ALDH1A1CYP1A2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US claimed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP claimed
JP-3110467-B2 2000-11-20 JP claimed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP claimed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO claimed
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed